Company / Free Cash Flow
Fortress Biotech, Inc. Free Cash Flow History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$128.3M
FY2024
5-year range
-$182.1M / -$85.6M
FY2020-FY2024
Trend
+29.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow returned to growth in FY2024 after 2 years of decline, reaching -$128M.
Based on SEC 10-K filings.
-$128M in FY2024.
Declined from -$121M to -$128M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, free cash flow increased 29.6% year-over-year.
- Peak free cash flow was recorded in FY2016.
- Lowest free cash flow in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -$128.3M | +29.6% |
| FY2023 | -$182.1M | -50.4% |
| FY2022 | -$121.1M | -41.5% |
| FY2021 | -$85.6M | +12.0% |
| FY2020 | -$97.3M | +8.1% |
| FY2019 | -$105.9M | -29.3% |
| FY2018 | -$82.0M | -296.7% |
| FY2017 | -$20.7M | -26.5% |
| FY2016 | -$16.3M | +45.0% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026